Rafael Holdings (RFL)

• Market cap: $58M
• 1 day: 8.33%
• 5 days: 1.56%
• 1 month: 0.00%
• 3 months: 13.37%
• 6 months: 33.56%
• Year to date: 6.56%
• 1 year: 6.56%
• 5 years: -88.76%
• 10 years: -60.20%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

Employees: 31

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

26% more capital invested

Capital invested by funds: $3.63M [Q2] → $4.58M (+$953K) [Q3]

0.72% less ownership

Funds ownership: 10.59% [Q2] → 9.87% (-0.72%) [Q3]

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

23% less funds holding

Funds holding: 43 [Q2] → 33 (-10) [Q3]

77% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 13